Accessibility version: https://youtu.be/0ip5imNzLY4 - PowerPoint PPT Presentation

Accessibility version: https://youtu.be/0ip5imNzLY4

      

      ‒ ‒

         ‒

        ‒ ‒ ‒

        ‒

        

MMR coverage from 1995 to 2011 Increased from 88% to 92% for Hispanic children Increased from 87% to 91% for Black children Remained at or above 91% for White children 1995-2011 NIS data available at: http://www.cdc.gov/vaccines/stats-surv/nis/default.htm#nis

http://www.cdc.gov/nchs/nis.htm

1989 1991 Epidemic 1963 Vaccine licensed 1993 VFC 2000 Elimination declared 1989 – 2 nd Dose recommended

Polio coverage from 1995 to 2011 From 2007 2011, no significant coverage Increased from 87% to 93% for Hispanic children differences among Increased from 84% to 93% for Black children these 3 groups Increased from 89% to 93% for White children http://www.cdc.gov/nchs/nis.htm 1995 2011 NIS data available at: http://www.cdc.gov/vaccines/stats-surv/nis/default.htm#nis

DTaP coverage from 1995 to 2011 Increased from 75% to 84% for Hispanic children Increased from 74% to 81% for Black children Increased from 80% to 85% for White children http://www.cdc.gov/nchs/nis.htm 1995 2011 NIS data available at: http://www.cdc.gov/vaccines/stats-surv/nis/default.htm#nis

     

   

         

      

      

      

NNDSS, National Notifiable Diseases Surveillance System MMWR 1999;48 (RR 12)

§ §

      

   

, ≥1 dose , ≥2 doses , ≥2 doses Ages 24 – 35 months Ages 19 – 35 months Ages 13 – 17 years 100 100 100 75 75 75 50 50 50 25 25 25 0 0 0 Nationally http://www.cdc.gov/nchs/nis.htm

100 25 50 75 0 Year

       

     

      

          

           – –

           

           AN, Alaska Native McMahon, BJ et al. Hepatology 2011;54:801 – 7

Incidence of Symptomatic Hepatitis B in Alaska Natives, 1981 – 2010 McMahon, BJ et al. Hepatology 2011;54:801 – 7

           AN, Alaska Native National Immunization Survey, http://www.cdc.gov/nchs/nis.htm McMahon, BJ et al. Hepatology 2011;54:801 – 7

McMahon, BJ et al. Hepatology 2011;54:801 – 7

McMahon, BJ et al. Hepatology 2011;54:801 – 7

           

              – – –

PRP-OMP vaccine introduced Change in vaccine Return to PRP-OMP vaccine Pediatrics 2006;118;e421-e429 ; doi: 10.1542/peds.2006-0287

–

        

      NIS, National Immunization Survey, http://www.cdc.gov/nchs/nis.htm –

         

         

 

 

   – 5

http://www.cdc.gov/nchs/nis.htm

  

  

     

   

Global Immunization 1980 010 Global Coverage of DTP3 at 85% in 2010

       

Cost to Vaccinate One Child with Vaccines Universally Cost to Vaccinate One Child with Vaccines Universally Recommended from Birth through 18 Years of Age Recommended from Birth through 18 Years of Age 1990, 2000, and 2012 1990, 2000, and 2012 $1,800 $1,712 HPV $1,600 rotavirus $1,400 hep A MCV $1,200 Td/Tdap $1,000 flu PCV13 $800 varicella $518 $600 hep B Hib $400 MMR $176 polio $200 DTaP $0 1990 2000 2012 2012 represents minimum cost to vaccinate a child (birth through 18); exceptions are 1) no preservative influenza vaccine, which is included for children 6 – 47 months of age, and 2) HPV for males and females Federal contract prices as of February 1, 1990, September 27, 2000, and April 24, 2012

* DTP/HepB/Hib

www.gavialliance.org

˗ ˗

       

   